{"disease":{"id":"safety-and-tolerability-in-healthy-volunteers","name":"safety and tolerability in healthy volunteers"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03672604","title":"A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":96,"lead_sponsor_name":"Neuraly, Inc.","has_results":false},{"nct_id":"NCT04783545","title":"Phase I Study of VLX-1005 in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":96,"lead_sponsor_name":"Veralox Therapeutics","has_results":false},{"nct_id":"NCT04034784","title":"Discrete(TM) Safety Clinical Trial GLAD-01","phase":"NA","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"ARC Medical Inc.","has_results":false},{"nct_id":"NCT04535752","title":"A Single and Multiple Ascending Dose Study of ANX009 in Normal Healthy Volunteers (NHV)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Annexon, Inc.","has_results":false},{"nct_id":"NCT06894875","title":"Effects of Lentil Protein Hydrolysate on Blood Pressure Control, Vascular Function and Exercise Performance","phase":"NA","overall_status":"RECRUITING","enrollment_count":48,"lead_sponsor_name":"Nuritas Ltd","has_results":false},{"nct_id":"NCT06715163","title":"Evaluation of the Safety and Tolerability of Three Doses of Diamine Oxidase (DAO) in Healthy Volunteers","phase":"NA","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"AB Biotek","has_results":false},{"nct_id":"NCT04085224","title":"6x3 Crossover, Bioavailability, Safety and Tolerability Among Different Eutropin Formulations in Healthy Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"LG Chem","has_results":false},{"nct_id":"NCT07346690","title":"A Study Testing the Effects of Different THC Doses on Psychological and Biological Function","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":24,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT07300202","title":"CLINICAL RESEARCH PROTOCOL [A Phase I, Single-arm, Open-label, Dose-escalation Clinical Study to Evaluate the Safety and Tolerability of Orialpha (BD-C) in Healthy Adult Volunteers]","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Oriplantee Company Limited","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}